Validation of miRNAs as Breast Cancer Biomarkers with a Machine Learning Approach
Certain small noncoding microRNAs (miRNAs) are differentially expressed in normal tissues and cancers, which makes them great candidates for biomarkers for cancer. Previously, a selected subset of miRNAs has been experimentally verified to be linked to breast cancer. In this paper, we validated the...
Main Authors: | Oneeb Rehman, Hanqi Zhuang, Ali Muhamed Ali, Ali Ibrahim, Zhongwei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/3/431 |
Similar Items
-
A Machine Learning Approach for the Classification of Kidney Cancer Subtypes Using miRNA Genome Data
by: Ali Muhamed Ali, et al.
Published: (2018-11-01) -
Exosomal MiRNAs in Pediatric Cancers
by: Angela Galardi, et al.
Published: (2019-09-01) -
Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer
by: Katiusse Alves dos Santos, et al.
Published: (2021-12-01) -
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
by: Ida Manna, et al.
Published: (2020-09-01) -
miRNAs as radio‐response biomarkers for breast cancer stem cells
by: Carmen Griñán‐Lisón, et al.
Published: (2020-03-01)